Volume 19 Number 9
30 September 2017

Home > Publications > Current Neuro-Oncology > Volume 19, Year 2017 > Number 9, 30 September

Salma S, Djan I, Bjelan M, Vulekovic P, Novakovic M, Vidovic V, Lucic M.
Benefit and outcome of using temozolomide-based chemoradiotherapy followed by temozolomide alone for glioblastoma in clinical practice.
J BUON. 2017 Sep-Oct;22(5):1233-1239
. PMID: 29135107. Observational study. ˍ

Nowosielski M, Ellingson BM, Chinot OL, Garcia J, Revil C, Radbruch A, Nishikawa R, Mason WP, Henriksson R, Saran F, Kickingereder P, Platten M, Sandmann T, Abrey LE, Cloughesy TF, Bendszus M, Wick W.
Radiologic progression of glioblastoma under therapy - an exploratory analysis of AVAglio.
Neuro Oncol. 2017 Sep 1,
2018;20(4):557-566. doi: 10.1093/neuonc/nox162. PMID: 29016943. Interventional study. ˍ

Phuong PC, Hung NQ, Ngoc TB, Rades D, Khoa MT.
Rotating Gamma System Irradiation: A Promising Treatment for Low-grade Brainstem Gliomas.
In Vivo. 2017 Sep 7, 2017;31(5):957-960
. doi: 10.21873/invivo.11153. PMID: 28882965. Interventional study. ˍ

Shi W, Scannell Bryan M, Gilbert MR, Mehta MP, Blumenthal DT, Brown PD, Valeinis E, Hopkins K, Souhami L, Andrews DW, Tzuk-Shina T, Howard SP, Youssef EF, Lessard N, Dignam JJ, Werner-Wasik M.
Investigating the Effect of Reirradiation or Systemic Therapy in Patients With Glioblastoma After Tumor Progression: A Secondary Analysis of NRG Oncology/Radiation Therapy Oncology Group Trial 0525.
Int J Radiat Oncol Biol Phys. 2017 Sep 4,
2018;100(1):38-44. doi: 10.1016/j.ijrobp.2017.08.038. PMID: 29102648. Observational study. ˍ

Aiken R, Axelson M, Harmenberg J, Klockare M, Larsson O, Wassberg C.
Phase I clinical trial of AXL1717 for treatment of relapsed malignant astrocytomas: analysis of dose and response.
Oncotarget. 2017 Sep 6, 2017;8(46):81501-81510
. doi: 10.18632/oncotarget.20662. PMID: 29113409. Interventional study. ˍ

Belcher SM, Burton CC, Cookman CJ, Kirby M, Miranda GL, Saeed FO, Wray KE.
Estrogen and soy isoflavonoids decrease sensitivity of medulloblastoma and central nervous system primitive neuroectodermal tumor cells to chemotherapeutic cytotoxicity.
BMC Pharmacol Toxicol. 2017 Sep 6, 2017;18(1):63
. doi: 10.1186/s40360-017-0160-7. PMID: 28877739. Laboratory investigation. ˍ

Scoccianti S, Krengli M, Marrazzo L, Magrini SM, Detti B, Fusco V, Pirtoli L, Doino D, Fiorentino A, Masini L, Greto D, Buglione M, Rubino G, Lonardi F, Migliaccio F, Marzano S, Santoni R, Ricardi U, Livi L.
Hypofractionated radiotherapy with simultaneous integrated boost (SIB) plus temozolomide in good prognosis patients with glioblastoma: a multicenter phase II study by the Brain Study Group of the Italian Association of Radiation Oncology (AIRO).
Radiol Med. 2017 Sep 6,
2018;123(1):48-62. doi: 10.1007/s11547-017-0806-y. PMID: 28879459. Interventional study. ˍ

Paisan GM, Buell TJ, Raper D, Asthagiri A.
Lumbosacral Subdural Hematoma After Glioblastoma Multiforme Resection: Possible Radiographic Evidence for the Downward Migration of Intracranial Blood.
World Neurosurg. 2017 Sep 7, 2017;108:993.e13-993.e17
. doi: 10.1016/j.wneu.2017.08.189. PMID: 28890010. Case report. ˍ

Hocking MC, Hobbie W, Fisher MJ.
Development of the Pediatric Neuro-Oncology Rating of Treatment Intensity (PNORTI).
J Neurooncol. 2017 Sep 8, 2018;136(1):73-78
. doi: 10.1007/s11060-017-2618-2. PMID: 28887756. Observational study. ˍ

Scobioala S, Parfitt R, Matulat P, Kittel C, Ebrahimi F, Wolters H, Am Zehnhoff-Dinnesen A, Eich HT.
Impact of radiation technique, radiation fraction dose, and total cisplatin dose on hearing: Retrospective analysis of 29 medulloblastoma patients.
Strahlenther Onkol. 2017 Sep 8,
2017;193(11):910-920. doi: 10.1007/s00066-017-1205-y. PMID: 28887665. Observational study. ˍ


Saito T, Sugiyama K, Hama S, Yamasaki F, Takayasu T, Nosaka R, Muragaki Y, Kawamata T, Kurisu K.
Prognostic importance of temozolomide-induced neutropenia in glioblastoma, IDH-wildtype patients.
Neurosurg Rev. 2017 Sep 9, 2018;41(2):621-628
. doi: 10.1007/s10143-017-0903-3. PMID: 28887717. Observational study. ˍ

Orzan F, De Bacco F, Crisafulli G, Pellegatta S, Mussolin B, Siravegna G, D'ambrosio A, Comoglio PM, Finocchiaro G, Boccaccio C.
Genetic Evolution of Glioblastoma Stem-like Cells from Primary to Recurrent Tumor.
Stem Cells. 2017 Sep 12,
2017;35(11):2218-2228. doi: 10.1002/stem.2703. PMID: 28895245. Laboratory investigation. ˍ

Jayamanne D, Wheeler H, Cook R, Teo C, Brazier D, Schembri G, Kastelan M, Guo L, Back MF.
Survival improvements with adjuvant therapy in patients with glioblastoma.
ANZ J Surg. 2017 Sep 18, 2018;88(3):196-201. doi: 10.1111/ans.14153. PMID: 28922698. Observational study. ˍ

Bradley CA.
Glioblastoma: Stem cells - masters of their fates.
Nat Rev Cancer. 2017 Sep 25, 2017;17(10):574-575. doi: 10.1038/nrc.2017.88. PMID: 28943636. Comment. ˍ
Refers to: Lan X et al, Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy.
Nature. 2017 Aug 30, 2017;549(7671):227-232. doi: 10.1038/nature23666. PMID: 28854171
. Laboratory investigation. ˍ

Nael K, Bauer AH, Hormigo A, Lemole M, Germano IM, Puig J, Stea B.
Multiparametric MRI for Differentiation of Radiation Necrosis From Recurrent Tumor in Patients With Treated Glioblastoma.
AJR Am J Roentgenol. 2017 Sep 27, 2018;210(1):18-23. doi: 10.2214/AJR.17.18003. PMID: 28952810. Observational study. ˍ